Amgen admits guilt, accepts $762 million fine for marketing practices with anemia drug

The biotechnology giant Amgen pleaded guilty Tuesday to illegally marketing its anemia drug Aranesp and agreed to pay $762 million in criminal penalties and settlements of whistle-blower lawsuits.



http://www.dailynews.com/business/ci_22216187/amgen-admits-guilt-accepts-762-million-fine-marketing.html